These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8552791)

  • 1. Antithrombotic therapy in atrial fibrillation: a review of randomized trials with special reference to the Stroke Prevention in Atrial Fibrillation II (SPAF II) Trial.
    Shivkumar K; Jafri SM; Gheorghiade M
    Prog Cardiovasc Dis; 1996; 38(4):337-42. PubMed ID: 8552791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term antithrombotic treatment for atrial fibrillation.
    Nademanee K; Kosar EM
    Am J Cardiol; 1998 Oct; 82(8A):37N-42N. PubMed ID: 9809899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
    Hart RG; Halperin JL; Pearce LA; Anderson DC; Kronmal RA; McBride R; Nasco E; Sherman DG; Talbert RL; Marler JR;
    Ann Intern Med; 2003 May; 138(10):831-8. PubMed ID: 12755555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.
    Man-Son-Hing M; Laupacis A; O'Connor AM; Biggs J; Drake E; Yetisir E; Hart RG
    JAMA; 1999 Aug; 282(8):737-43. PubMed ID: 10463708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
    Deedwania PC; Huang GW
    Am J Cardiovasc Drugs; 2011 Aug; 11(4):265-75. PubMed ID: 21740079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
    Yuan C; Zhong L; Huang RC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):526-535. PubMed ID: 28648031
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice.
    Osseby GV; Benatru I; Sochurkova D; Urbinelli R; Megherbi SE; Couvreur G; Moreau T; Wolf J; Giroud M
    Prev Med; 2004 Feb; 38(2):121-8. PubMed ID: 14715203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient values and preferences for antithrombotic therapy in atrial fibrillation. A Narrative Systematic Review.
    Loewen PS; Ji AT; Kapanen A; McClean A
    Thromb Haemost; 2017 Jun; 117(6):1007-1022. PubMed ID: 28276567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
    Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators.
    Stroke; 1990 Apr; 21(4):538-45. PubMed ID: 2183405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
    Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
    Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-thrombotic therapy for non-rheumatic atrial fibrillation.
    More RS; Chauhan A
    QJM; 1996 Jun; 89(6):409-14. PubMed ID: 8758043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
    Hu DY; Zhang HP; Sun YH; Jiang LQ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):295-8. PubMed ID: 16776915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombotic therapy of atrial fibrillation].
    Mélon P
    Rev Med Liege; 2000 Apr; 55(4):297-301. PubMed ID: 10909317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontiers in prevention of thromboembolism in nonvalvular atrial fibrillation].
    Fukunami M
    J Cardiol; 1999 Mar; 33 Suppl 1():65-70. PubMed ID: 10342139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.
    Halperin JL
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):163-74. PubMed ID: 15151465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.